Anti-angiogenic Drugs as Chemosensitizers in Cancer Therapy presents updated reviews on anti-angiogenic drugs used in tumor therapy. It focuses on the use of anti-angiogenic drugs as sensitizers of tumor cells to the inhibitory activity of antitumor agents. Conventional and novel anti-neoplastic agents (cytotoxic molecules, hormones/antihormones, immunotherapies) are taken in consideration as well as the advances made in combination therapies recently. The book encompasses examples of studies on the use of antiangiogenic compounds, molecules that inhibit the growth of vessels inside a tumor, together with antineoplastic drugs, in order to sensitize the resistant tumor to their cytotoxic effects, thus reducing adverse side reactions and resistance and improving the therapeutic response of cancer patients. In addition, it discusses clinical applications in various types of cancer, such as colorectal, lung, breast, renal, genitourinary, skin, and brain and circulating tumors. It is a valuable resource for cancer researchers, clinicians and members of biomedical field who wants to be up to date with the most recent and promising developments of the field.

Book Information
ISBN 9780323901901
Author Lucia Morbidelli
Format Hardback
Page Count 400
Imprint Academic Press Inc
Publisher Elsevier Science & Technology
Weight(grams) 191g